NexGel Inc (NXGL)
2.59
-0.03
(-1.14%)
USD |
NASDAQ |
Sep 27, 16:00
2.58
-0.01
(-0.39%)
After-Hours: 20:00
NexGel SG&A Expense (TTM): 4.484M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 4.484M |
March 31, 2024 | 3.973M |
December 31, 2023 | 3.659M |
September 30, 2023 | 3.141M |
June 30, 2023 | 2.972M |
March 31, 2023 | 2.822M |
December 31, 2022 | 2.789M |
September 30, 2022 | 2.931M |
June 30, 2022 | 2.757M |
March 31, 2022 | 2.647M |
December 31, 2021 | 2.381M |
September 30, 2021 | 2.062M |
Date | Value |
---|---|
June 30, 2021 | 2.02M |
March 31, 2021 | 1.932M |
December 31, 2020 | 2.064M |
September 30, 2020 | 1.815M |
June 30, 2020 | 1.307M |
March 31, 2020 | 1.859M |
December 31, 2019 | 1.787M |
September 30, 2019 | 2.26M |
June 30, 2019 | 3.004M |
March 31, 2019 | 2.569M |
December 31, 2018 | 2.406M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
1.307M
Minimum
Jun 2020
4.484M
Maximum
Jun 2024
2.583M
Average
2.514M
Median
SG&A Expense (TTM) Benchmarks
The Cooper Companies Inc | 1.530B |
Staar Surgical Co | 187.72M |
OrthoPediatrics Corp | 146.94M |
Innovative Eyewear Inc | 7.117M |
Perspective Therapeutics Inc | 18.64M |